92 related articles for article (PubMed ID: 28640095)
21. Associations of stem cell markers in benign breast tissue with subsequent breast cancer risk.
Yaghjyan L; Heng YJ; Baker GM; Murthy D; Mahoney MB; Rosner B; Tamimi RM
Am J Cancer Res; 2023; 13(12):6280-6289. PubMed ID: 38187066
[TBL] [Abstract][Full Text] [Related]
22. Association of molecular subtypes and treatment with survival in invasive micropapillary breast cancer: an analysis of the Surveillance, Epidemiology, and End Results database.
Tang Z; Li L; Huang X; Zhao Y; Huang L
Breast Cancer; 2024 Mar; 31(2):205-216. PubMed ID: 38043116
[TBL] [Abstract][Full Text] [Related]
23. A comparative study of smart nanoformulations of diethyldithiocarbamate with Cu
Abu-Serie MM; Abdelfattah EZA
Sci Rep; 2023 Mar; 13(1):3529. PubMed ID: 36864097
[TBL] [Abstract][Full Text] [Related]
24. Reliability of CD44, CD24, and ALDH1A1 immunohistochemical staining: Pathologist assessment compared to quantitative image analysis.
Yaghjyan L; Heng YJ; Baker GM; Bret-Mounet V; Murthy D; Mahoney MB; Mu Y; Rosner B; Tamimi RM
Front Med (Lausanne); 2022; 9():1040061. PubMed ID: 36590957
[TBL] [Abstract][Full Text] [Related]
25. How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance.
Ciccone V; Morbidelli L; Ziche M; Donnini S
Cancer Drug Resist; 2020; 3(1):26-37. PubMed ID: 35582039
[TBL] [Abstract][Full Text] [Related]
26. Isolation and Establishment of a Highly Proliferative, Cancer Stem Cell-Like, and Naturally Immortalized Triple-Negative Breast Cancer Cell Line, KAIMRC2.
Ali R; Al Zahrani H; Barhoumi T; Alhallaj A; Mashhour A; Alshammari MA; Alshawakir YA; Baz O; Alanazi AH; Khan AL; Al Nikhli H; Al Balwi MA; Al Riyees L; Boudjelal M
Cells; 2021 May; 10(6):. PubMed ID: 34073849
[TBL] [Abstract][Full Text] [Related]
27. Effect of HPV 16 E6 Oncoprotein Variants on the Alterations of the Proteome of C33A Cells.
Garibay-Cerdenares OL; Sánchez-Meza LV; Encarnación-Guevara S; Hernández-Ortíz M; Martínez-Batallar G; Torres-Rojas FI; Mendoza-Catalán MÁ; Moral-Hernández OD; Leyva-Vázquez MA; Illades-Aguiar B
Cancer Genomics Proteomics; 2021; 18(3):273-283. PubMed ID: 33893080
[TBL] [Abstract][Full Text] [Related]
28. CTCs Expression Profiling for Advanced Breast Cancer Monitoring.
Pereira-Veiga T; Martínez-Fernández M; Abuin C; Piñeiro R; Cebey V; Cueva J; Palacios P; Blanco C; Muinelo-Romay L; Abalo A; Costa C; López-López R
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817194
[TBL] [Abstract][Full Text] [Related]
29. Emerging insights into the biology of metastasis: A review article.
Irani S
Iran J Basic Med Sci; 2019 Aug; 22(8):833-847. PubMed ID: 31579438
[TBL] [Abstract][Full Text] [Related]
30. Proteomics-Metabolomics Combined Approach Identifies Peroxidasin as a Protector against Metabolic and Oxidative Stress in Prostate Cancer.
Dougan J; Hawsawi O; Burton LJ; Edwards G; Jones K; Zou J; Nagappan P; Wang G; Zhang Q; Danaher A; Bowen N; Hinton C; Odero-Marah VA
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234468
[TBL] [Abstract][Full Text] [Related]
31. Exploring the Mechanism of Flavonoids Through Systematic Bioinformatics Analysis.
Qiu T; Wu D; Yang L; Ye H; Wang Q; Cao Z; Tang K
Front Pharmacol; 2018; 9():918. PubMed ID: 30158870
[TBL] [Abstract][Full Text] [Related]
32.
Kasten BB; Oliver PG; Kim H; Fan J; Ferrone S; Zinn KR; Buchsbaum DJ
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561763
[TBL] [Abstract][Full Text] [Related]
33. Ultrasound combined with fine needle aspiration cytology for the assessment of axillary lymph nodes in patients with early stage breast cancer.
Zhang F; Zhang J; Meng QX; Zhang X
Medicine (Baltimore); 2018 Feb; 97(7):e9855. PubMed ID: 29443748
[TBL] [Abstract][Full Text] [Related]
34. Differential Proteome Analysis of Extracellular Vesicles from Breast Cancer Cell Lines by Chaperone Affinity Enrichment.
Griffiths SG; Cormier MT; Clayton A; Doucette AA
Proteomes; 2017 Oct; 5(4):. PubMed ID: 28991197
[TBL] [Abstract][Full Text] [Related]
35. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC
Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095
[TBL] [Abstract][Full Text] [Related]
36. Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.
Ohi Y; Umekita Y; Yoshioka T; Souda M; Rai Y; Sagara Y; Sagara Y; Sagara Y; Tanimoto A
Histopathology; 2011 Oct; 59(4):776-80. PubMed ID: 22014057
[TBL] [Abstract][Full Text] [Related]
37. Expression of ALDH1 and TGFβ2 in benign and malignant breast tumors and their prognostic implications.
Zheng R; Wang J; Wu Q; Wang Z; Ou Y; Ma L; Wang M; Wang J; Yang Y
Int J Clin Exp Pathol; 2014; 7(7):4173-83. PubMed ID: 25120797
[TBL] [Abstract][Full Text] [Related]
38. Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.
Morimoto K; Kim SJ; Tanei T; Shimazu K; Tanji Y; Taguchi T; Tamaki Y; Terada N; Noguchi S
Cancer Sci; 2009 Jun; 100(6):1062-8. PubMed ID: 19385968
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Chen J; Xia Q; Jiang B; Chang W; Yuan W; Ma Z; Liu Z; Shu X
PLoS One; 2015; 10(12):e0145164. PubMed ID: 26682730
[TBL] [Abstract][Full Text] [Related]
40. ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis.
Liu Y; Lv DL; Duan JJ; Xu SL; Zhang JF; Yang XJ; Zhang X; Cui YH; Bian XW; Yu SC
BMC Cancer; 2014 Jun; 14():444. PubMed ID: 24938375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
